Caroverine
Clinical data | |
---|---|
Routes of administration | Oral |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C22H27N3O2 |
Molar mass | 365.47 g/mol |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
WikiDoc Resources for Caroverine |
Articles |
---|
Most recent articles on Caroverine |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Caroverine at Clinical Trials.gov Clinical Trials on Caroverine at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Caroverine
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Caroverine Discussion groups on Caroverine Patient Handouts on Caroverine Directions to Hospitals Treating Caroverine Risk calculators and risk factors for Caroverine
|
Healthcare Provider Resources |
Causes & Risk Factors for Caroverine |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Caroverine (Spasmium, Spadon, Tinnex) is a drug used as a spasmolytic and otoneuroprotective (inner ear protective) agent in some countries. It acts as an N-type calcium channel blocker, competitive AMPA receptor antagonist, and non-competitive NMDA receptor antagonist. It also has potent antioxidant effects.
Applications
Caroverine has been demonstrated to have a high rate of efficacy in the treatment of cochlear-synaptic tinnitus.
References
- Pages with script errors
- Drugs with non-standard legal status
- Articles with changed EBI identifier
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Drugboxes which contain changes to verified fields
- Quinoxalines
- Lactams
- Phenol ethers
- NMDA receptor antagonists
- Drug